Home
>>
Products
>>
Proteins
>>
Recombinant Proteins
>
Recombinant Human LR3 IGF-I Protein

Recombinant Human LR3 IGF-I Protein

Product Number

KRP683

Alias

Long R3 IGF-I, LR3 Insulin-like growth factor I, Insulin-like growth factor 1, IGF-I LR3, IGFI,

Specifications
  • 100ug
  • 500ug
  • 1mg
Product Description
AliasLong R3 IGF-I, LR3 Insulin-like growth factor I, Insulin-like growth factor 1, IGF-I LR3, IGFI,
Catalog NumberKRP683
Product IntroductionRecombinant human long-acting IGF-1 variant (LR3 IGF-1) has enhanced stability and biological activity. Suitable for long-term cell proliferation research, muscle regeneration experiments, and exploration of metabolic disease-related mechanisms.
Molecular NameIGF1
SpeciesHuman
HostE.coli
Size100ug,500ug,1mg
Purity>97%, determined by SDS-PAGE.
ConcentrationContact the sales manager to obtain the concentration of the latest batch.
PurificationAffinity Purification
Endotoxin<0.01 EU/μg, determined by LAL method.
BackgroundA long-acting analogue of IGF-1, which through amino acid substitutions and N-terminal extension peptide reduces its affinity for binding proteins , thereby enhancing its bioactivity and stability, mainly used for scientific research.
ApplicationWB, ELISA
Predicted Molecular Weight9 kDa
ReconstitutionIt is recommended that the lyophilized human LR3 IGF-I protein be dissolved in 100 mM Acetic Acid at a concentration of 100-200 μg/mL for further dilution as the working concentration.
Storage ConditionSamples are stable for up to twelve months from date of receipt at -20℃ to -87℃. Avoid repeated freeze-thaw cycles.
Shipping ConditionThis product is shipped on ice packs or dry ice.
StabilityRepeated freezing and thawing is not recommended.
Molecular Weight8 kDa,
Uniprot IDP05019
References1. Philippou, A. et al. (2007) In Vivo 21:45. 2. Sandberg-Nordqvist, A.C. et al. (1992) Brain Res. Mol. Brain Res. 12:275. 3. Berryman, D.E. et al. (2013) Nat. Rev. Endocrinol. 9:346. 4. Guvakova, M.A. (2007) Int. J. Biochem. Cell Biol. 39:890. 5. Sadagurski, M. and M.F. White (2013) Endocrinol. Metab. Clin. North Am. 42:127. 6. Clemmons, D.R. (2006) Curr. Opin. Pharmacol. 6:620. 7. Bluher, S. et al. (2005) Best Pract. Res. Clin. Endocrinol. Metab. 19:577. 8. Garcia-Segura, L.M. et al. (2006) Neuroendocrinology 84:275. 9. Malemud, C.J. (2007) Clin. Chim. Acta 375:10. 10. Ling, P.R. et al. (1995) Am. J. Clin. Nutr. 61:116. 11. Sheng, M.H. et al. (2014) J. Bone Metab. 21:41. 12. Samani, A.A. et al. (2007) Endocrine Rev. 28:20. 13. Gallagher, E.J. et al. (2010) Endocr. Pract. 16:864. 14. LeRoith, D. and S. Yakar (2007) Nat. Clin. Pract. Endocrinol. Metab. 3:302. 15. Denley, A. et al. (2005) Cytokine Growth Factor Rev. 16:421. 16. Duan, C. and Q. Xu (2005) Gen. Comp. Endocrinol. 142:44. 17. Francis, G.L. et al. (1992) J. Mol. Endocrinol. 8:213. 18. Voorhamme, D. and C.A. Yandell (2006) Mol. Biotechnol. 34:201. 19. Tomas, F.M. et al. (1993) Biochem. J. 291:781. 20. Tomas, F.M. et al. (1996) J. Endocrinol. 150:77. 21. Tomas, F.M. et al. (1997) J. Endocrinol. 155:377. 22. von der Thüsen, J.H. et al. (2011) Am. J. Pathol. 178:924
FunctionRecombinant human long-acting IGF-1 variant (LR3 IGF-1) has enhanced stability and bioactivity. It is suitable for long-term cell proliferation research, muscle regeneration experiments, and exploration of mechanisms related to metabolic diseases.
Product DeclarationThis product is for research use only and must not be used directly on the human body or for injection.
Temperature RangeStore the product under sterile conditions after opening at -80℃ for 12 months. Store the lyophilized powder at -27℃. Avoid repeated freeze-thaw cycles.
Product Full NameRecombinant Human LR3 IGF-I Protein
TargetLR3 IGF-I
FAQ
  • What is the difference between LR3 IGF-1 and regular IGF-1?

    It is an analog of IGF-1, with stronger binding affinity to the IGF-1 receptor, and its half-life in the body is significantly prolonged.

  • When should it be used in culture?

    When a stronger and more durable growth-promoting and anti-apoptotic signal is needed, such as during high-density stem cell expansion or when cells are under stress conditions.

Login

Don’t have an account?Sign Up Now

Register

Already have an account?Log In Now

Inquire Now